Phase II Study of Cryoablation and Post-Progression Immune Checkpoint Inhibition in Metastatic Melanoma

Pembrolizumab versus Ipilimumab in Advanced Melanoma.

C. Robert, J. Schachter, G. Long, et al.. (2015). The New England journal of medicine. Cited 5,165 times. https://doi.org/10.1056/NEJMoa1503093

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, et al.. (2018). Cell. Cited 1,573 times. https://doi.org/10.1016/j.cell.2018.10.038

Novel patterns of response under immunotherapy

E. Borcoman, Y. Kanjanapan, S. Champiat, et al.. (2019). Annals of Oncology. Cited 430 times. https://doi.org/10.1093/annonc/mdz003

Cryoablation: mechanism of action and devices.

J. Erinjeri, T. Clark. (2010). Journal of vascular and interventional radiology : JVIR. Cited 370 times. https://doi.org/10.1016/j.jvir.2009.12.403

Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE).

M. Callstrom, D. Woodrum, F. Nichols, et al.. (2020). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Cited 93 times. https://doi.org/10.1016/j.jtho.2020.02.022

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors

Chakradhar Yakkala, C. Chiang, L. Kandalaft, et al.. (2019). Frontiers in Immunology. Cited 71 times. https://doi.org/10.3389/fimmu.2019.02283

Percutaneous Cryoablation: Safety and Efficacy for Pain Palliation of Metastases to Pleura and Chest Wall.

F. Fintelmann, Platon Braun, S. Mirzan, et al.. (2019). Journal of vascular and interventional radiology : JVIR. Cited 24 times. https://doi.org/10.1016/j.jvir.2019.09.013